124
Views
17
CrossRef citations to date
0
Altmetric
Review

Current strategies for managing interstitial cystitis

Pages 287-293 | Published online: 02 Mar 2005

Bibliography

  • PARSONS CL, ZUPKAS P, PARSONS JK: Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology (2001) 57:428–433.
  • HAND JR: Interstitial cystitis, a report of 223 cases.' Urol. (1949) 61:291–310.
  • •An early article describing the distinctive clinical syndrome of IC in a large group of patients.
  • PARSONS CL: Interstitial cystitis: clinical manifestations and diagnostic criteria in over 200 cases. Neuronic] Urodyn. (1990) 9:241–250.
  • KOZIOL JA, CLARK DC, GITTES RE TAN EM: The natural history of interstitial cystitis: A survey of 374 patients. J. Urol. (1993) 149:465–469.
  • PARSONS CL, DELL J, STANFORD EJ et al.: Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology (2002) 60:573–578.
  • ••A controlled validation study of PLTF Scaleagainst PST results in 334 patients and PUF screening of 317 women from the general population.
  • PARSONS CL, DELL J, STANFORD EJ, BULLEN M, KAHN BS, WILLEMS JJ: The prevalence of interstitial cystitis in gynecologic patients with pelvic pain as detected by intravesical potassium sensitivity. Am. J. Obster Cynecol (2002) 187:1395–1400.
  • PARSONS CL, ALBO ME: Intravesical potassium sensitivity in prostatitis patients. Urol. (2002) 168:1054–1057.
  • KOZIOL JA: Epidemiology of interstitial cystitis. Urol. Clin. North Am. (1994) 21:7–71.
  • HELD PJ, HANNO PM, WEIN AJ et al:Epidemiology of interstitial cystitis: 2. In: Interstitial Cystitis Hanno PM, Staskin DR, Krane RI et al. (Eds). Springer-Verlag, London (1990):29–48.
  • PARSONS CL: Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology (2003) 62:976–982.
  • ••A review of the evidence for epithelialdysfunction and potassium recycling in the pathogenesis of IC.
  • LILLY JD, PARSONS CL: Bladder surface glycosaminoglycans as a human epithelial permeability barrier. Surg. Cynecol °Lister (1990) 171:493–496.
  • PARSONS CL, STEIN PC, BIDAIR M et al.: Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neuronic] Urodyn. (1994) 3:515–520.
  • PAYNE CK, BROWNING S: Graded potassium chloride testing in interstitial cystitis. J. Urol. (1996) 155(Suppl.):438A.
  • PARSONS CL, GREENBERGER M, GABAL L et al.: The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J. Urol. (1998) 159:1862–1867.
  • ••A report of studies showing that asymptomatic reaction to potassium in the bladder is abnormal and indicates epithelial dysfunction.
  • CHAMBERS GK, FENSTER HN, CRIPPS S et al.: An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J. Urol. (1999) 162:699–701.
  • TEICHMAN JMH,NIELSEN-OMEIS BJ: Potassium leak testpredicts outcome in interstitial cystitis. Urol. (1999) 161:1791–1794.
  • CHEN TY-H, BEGIN LR, CORCOS J: Assessment of potassium chloride test in comparison with symptomatology, cystoscopic findings and bladder biopsy in the diagnosis of interstitial cystitis. J. Urol. (2001) 165(Suppl.):67.
  • DAHA L, RIEDL CR, KNOLL M et al.: Comparative (saline versus 0.2M potassium chloride) assessment of maximum bladder capacity: a well tolerated alternative to the 0.4 M potassium sensitivity test (PST).Urol. (2001) 165(Suppl.):68.
  • FORREST JB, VO Q: Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology (2001) 57(Suppl. 6A):26–29.
  • KUO HC: Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. I FOIMOS. Med. ASSOC. (2001) 100:309–314.
  • GREGOIRE M, LIANDIER F, NAUD A et al.: Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis?' Urol. (2002) 168:556–557.
  • PARSONS CL, FORREST J, NICKEL JC et al.: Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology (2002) 59:329–333.
  • KUO HC: Urodynamic study and potassium sensitivity test for women with frequency-urgency syndrome and interstitial cystitis. Urol. Int. (2003) 71:61–65.
  • PARSONS CL, HOUSLEY T, SCHMIDT JD et al.: Treatment of interstitial cystitis with intravesical heparin. Urol. (1994) 73:504–507.
  • HO NJ, KOZIOL JA, PARSONS CL et al: Natural history of interstitial cystitis in 274 patients receiving sulfated polysaccharide therapy. Urology (1999) 53:1133–1139.
  • PARSONS CL, BENSON G, CHILDS SJ et al.: A quantitatively controlled method to prospectively study interstitial cystitis and which demonstrates the efficacy of pentosanpolysulfate. Urol. (1993) 150:845–848.
  • MULHOLLAND SG, HANNO P, PARSONS CL et al.: Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology (1990) 35:552–558.
  • PARSONS CL, MULHOLLAND SG: Successful therapy of interstitial cystitis with pentosanpolysulfate. Urol. (1987) 138:513–516.
  • HOLM-BENTZEN M, JACOBSEN F, NERSTROM B et al.: A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of292interstitial cystitis and related painful bladder disease. J. Urol. (1987) 138:503–507.
  • HANNO PM: Analysis of long-term Elmiron therapy for interstitial cystitis. Urology (1997) 49(Suppl. 5A):93–99.
  • ••A double-blind, open-phase study ofpentosan polysulfate in IC showing that response increases with duration of treatment.
  • NICKEL JC, BARKIN J, FORREST J et al.: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium (PPS) for interstitial cystitis (IC).Urol. (2001) 165(5 Suppl.):67.
  • ••A double-blind, open-phase study ofpentosan polysulfate in IC showing that response increases with duration of treatment.
  • PARSONS CL: Epithelial coating techniques in the treatment of interstitial cystitis. Urology (1997) 49(Suppl. 5A):100–104.
  • HENRY R, PATTERSON L, AVERY N et al.: Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. Urol. (2001) 165:1900–1903.
  • •Study showing sodium bicarbonate dramatically increases the intravesical absorption of lidocaine.
  • SANT GR: Interstitial cystitis:Pathophysiology, clinical evaluation and treatment. Ann. Urol. (1989) 3:172–179.
  • SANT GR, KALARU P, UCCI AA JR: Mucosal mast cell (MMC) contribution to bladder mastocytosis in interstitial cystitis. Urol. (1988) 139:276A.
  • LETOURNEAU R, PANG X, SANT GR et al.: Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br. J. Urol. (1996) 77:41–54.
  • HANNO PM, BUEHLER J, WEIN AJ: Use of amitriptyline in the treatment of interstitial cystitis. J. Urol. (1989) 141:846–848.
  • THEOHARIDES TC: Hydroxyzine in the treatment of interstitial cystitis. Urol. Clin. N. Arn. (1994) 21:113–119.
  • SANT GR, PROPERT KJ, HANNO PM et al.: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. (2003) 170:810–815.
  • DELL JR, PARSONS CL: Intravesical instillation therapy using pentosan polysulfate sodium (PPS) in patients with interstitial cystitis (IC). Abstract presented at NIDDK/Interstitial Cystitis Association Symposium, Research Insights into Interstitial Cystitis, Alexandria, VA, USAOctober 30 - November 1 (2003).
  • DAVIS EL, DAVIS J, REGAN L, TALBOTT EO: A prospective evaluation of intravesical instillation of pentosan polysulfate sodium (PPS; Elmiron, [Ortho-McNeil]) in patients withinterstitial cystitis: the association of clinical outcomes and symptom triad. Abstract presented at NIDDK/Interstitial Cystitis Association Symposium, Research Insights into Interstitial Cystitis, Alexandria, VA, USA October 30 - November 1 (2003).
  • PARSONS CL: Evidence-based strategies for recognizing and managing IC.Contemp. Urol. (2003) 15:22–24; 27–28; 31–32; 35.
  • PARSONS CL, DAVIS EL: Pentosan polysulfate sodium intravesical instillation - End-organ therapy. Practice Building Today (2003) September:18–22.
  • NICKEL JC, DOWNEY J, HUNTER D, CLARK J: Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J. Urol. (2001) 165:842–845.
  • •Reports the use of a symptom questionnaire to screen a general population of men for symptoms of chronic prostatitis, which in many cases may be IC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.